These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

43 related articles for article (PubMed ID: 3025737)

  • 1. Opiate-inhibited adenylate cyclase in mammalian brain membranes.
    Childers SR; Nijssen P; Nadeau P; Buckhanna P; Le PV; Harris J
    NIDA Res Monogr; 1986; 71():65-80. PubMed ID: 3025737
    [No Abstract]   [Full Text] [Related]  

  • 2. BW373U86: a nonpeptidic delta-opioid agonist with novel receptor-G protein-mediated actions in rat brain membranes and neuroblastoma cells.
    Childers SR; Fleming LM; Selley DE; McNutt RW; Chang KJ
    Mol Pharmacol; 1993 Oct; 44(4):827-34. PubMed ID: 8232233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modification of G protein-coupled functions by low-pH pretreatment of membranes from NG108-15 cells: increase in opioid agonist efficacy by decreased inactivation of G proteins.
    Selley DE; Breivogel CS; Childers SR
    Mol Pharmacol; 1993 Oct; 44(4):731-41. PubMed ID: 8232223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Opioid receptors].
    Minami M; Kaneko S; Satoh M
    Tanpakushitsu Kakusan Koso; 1997 Feb; 42(3 Suppl):335-42. PubMed ID: 9162968
    [No Abstract]   [Full Text] [Related]  

  • 5. Modification of receptor-mediated inhibition of adenylate cyclase in NG108-15 neuroblastoma X glioma cells by n-ethylmaleimide.
    Smith MM; Harden TK
    J Pharmacol Exp Ther; 1984 Feb; 228(2):425-33. PubMed ID: 6319678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opioid mu, delta, and kappa receptor-induced activation of phospholipase C-beta 3 and inhibition of adenylyl cyclase is mediated by Gi2 and G(o) in smooth muscle.
    Murthy KS; Makhlouf GM
    Mol Pharmacol; 1996 Oct; 50(4):870-7. PubMed ID: 8863832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opiate receptor-mediated inhibition of adenylate cyclase in rat striatal plasma membranes.
    Cooper DM; Londos C; Gill DL; Rodbell M
    J Neurochem; 1982 Apr; 38(4):1164-7. PubMed ID: 6278084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relationship between enkephalin degradation and opiate receptor occupancy.
    Knight M; Klee WA
    J Biol Chem; 1978 Jun; 253(11):3843-7. PubMed ID: 25892
    [No Abstract]   [Full Text] [Related]  

  • 9. Opiate receptors and their clinical implications.
    Spector S
    Circ Res; 1980 Jun; 46(6 Pt 2):I138-41. PubMed ID: 6247085
    [No Abstract]   [Full Text] [Related]  

  • 10. On the mechanism of receptor-mediated inhibition of adenylate cyclase.
    Klee WA; Koski G; Tocque B; Simonds WF
    Adv Cyclic Nucleotide Protein Phosphorylation Res; 1984; 17():153-9. PubMed ID: 6145318
    [No Abstract]   [Full Text] [Related]  

  • 11. The opiate receptor-binding interactions of opiate alkaloids and of an opioid peptide in rat brain membranes. Selection by manganese ions and by cholic acid (sodium salt) and minimalization of cross-reaction in vitro.
    Kouakou Y; Zajac JM; Moisand C; Meunier JC
    Mol Pharmacol; 1982 May; 21(3):564-9. PubMed ID: 6287195
    [No Abstract]   [Full Text] [Related]  

  • 12. [The effect of synthetic opiate-like peptides identical to protein fragments with different functions and their structural analogs on the basal activity of the striatal adenylate cyclase in the rat brain].
    Shestak KI; Kalikhevich VN; Ardemasova ZA
    Zh Evol Biokhim Fiziol; 1998; 34(2):157-62. PubMed ID: 9703661
    [No Abstract]   [Full Text] [Related]  

  • 13. Ultra-low-dose naloxone suppresses opioid tolerance, dependence and associated changes in mu opioid receptor-G protein coupling and Gbetagamma signaling.
    Wang HY; Friedman E; Olmstead MC; Burns LH
    Neuroscience; 2005; 135(1):247-61. PubMed ID: 16084657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A multiplicity of opiate receptors and enkephalin neuronal systems.
    Snyder SH
    J Clin Psychiatry; 1982 Jun; 43(6 Pt 2):9-12. PubMed ID: 6282818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opiate-induced enhancement of the effects of naloxone on serum luteinizing hormone levels in the male rat: specificity for Mu agonists.
    Cicero TJ; Owens DP; Schmoeker PF; Meyer ER
    J Pharmacol Exp Ther; 1983 Sep; 226(3):770-5. PubMed ID: 6310081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mu- and delta-opioid receptors inhibitorily linked to dopamine-sensitive adenylate cyclase in rat striatum display a selectivity profile toward endogenous opioid peptides different from that of presynaptic mu, delta and kappa receptors.
    Schoffelmeer AN; De Vries TJ; Hogenboom F; Mulder AH
    J Pharmacol Exp Ther; 1993 Oct; 267(1):205-10. PubMed ID: 8229747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparative activity of endorphins on the opiate receptors].
    Vallée E; Chambon JP; Delahayes J
    C R Acad Hebd Seances Acad Sci D; 1977 Jul; 285(3):257-60. PubMed ID: 198160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics of peptide and alkaloid opiate binding sites in brain and peripheral tissues.
    Cox BM; Leslie FM; Chavkin C
    Adv Biochem Psychopharmacol; 1980; 22():353-62. PubMed ID: 6249080
    [No Abstract]   [Full Text] [Related]  

  • 19. Different subtypes of opioid receptors have different affinities for G-proteins.
    Polastron J; Jauzac P
    Cell Mol Biol (Noisy-le-grand); 1994 May; 40(3):389-401. PubMed ID: 7920183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism for selectively inhibiting the activation of cyclic nucleotide phosphodiesterase and adenylate cyclase by antipsychotic agents.
    Weiss B; Levin RM
    Adv Cyclic Nucleotide Res; 1978; 9():285-303. PubMed ID: 27079
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.